The Conversation: ‘Off-label’ use is common in medicine…why COVID-19 vaccines are different
A UC bioethicist explains why the COVID-19 vaccines are different than other medicines
Elizabeth Lanphier, a clinical assistant professor of pediatrics at the UC College of Medicine and a research assistant professor in the UC Department of Philosophy, and Shannon Fyfe, assistant professor of philosophy and adjunct professor of law at George Mason University, co-authored an article in The Conversation, explaining their analysis on the potential for “off label” use of COVID-19 vaccines.
Elizabeth Lanphier, PhD. Photo/provided by Lanphier.
Off-label refers to the administration of an FDA-approved product for a different population, use or dosage than what it was approved for. It is a common practice in health care.
The FDA and the American Academy of Pediatrics have warned against off-label use of COVID-19 vaccines in kids; and the CDC prohibits it based on the COVID-19 vaccine provider agreement it has with pharmacies, hospitals and clinics that are administering COVID-19 vaccines.“Off-label vaccination is not a strategy for mass vaccination. But our research suggests that off-label use of COVID-19 vaccines is an ethically permissible option on a case-by-case basis,” says Lanphier.
Lanphier and Fyfe authored The Conversation article based on their recent analysis of the topic, which is published in The Hastings Report.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.